MCQ Book Questions

Q55414. The site of action of d-tubocurarine is

Q55415. The fall in blood pressure caused by d- tubocuranine is due to

Q55416. The neuromuscular blocker having prominent antivagal action is

Q55417. Neuromuscular blocking drugs do not produce central actions because

Q55418. Pancuronium differs from tubocurarine in that

Q55419. Muscarinic receptors are G-protein coupled receptors, causing

Q55420. Postoperative muscle soreness may be side effect of the following neuromuscular blocker

Q55421. Following drug enhances the evoked release of acetylcholine

Q55422. Which of the following muscle relaxants can be used to control spasticity associated with upper motor neurone paralysis ?

Q55423. Following muscarinic agonist is suscepti- ble to hydrolysis by cholinesterase

Q55424. Dihydroergotamine differs from ergota- mine in the following respect

Q55425. Select the ergot compound which is primarily used for dementia

Q55426. The ‘amine’ ergot alkaloid differs from ‘amino acid’ ergot alkaloids in that it has

Q55427. Select the correct statement in relation to drug therapy of migraine

Q55428. Ergotamine relieves migraine by

Q55429. Which of the following drugs is most com- monly used for prophylaxis of migraine ?

Q55430. Stimulation of exocrine glands by muscarinic agonist leads to

Q55431. Datura stramonium (thorn apple) mainly contains following muscarinic antagonist

Q55432. β-blockers are contraindicated in

Q55433. β-blockers are better avoided in